Reporting of conflicts of interest by authors of primary studies on health policy and systems research: a cross-sectional survey.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 07 2020
Historique:
entrez: 22 7 2020
pubmed: 22 7 2020
medline: 18 2 2021
Statut: epublish

Résumé

The objective of this study was to assess the frequency and types of conflict of interest (COI) disclosed by authors of primary studies of health policy and systems research (HPSR). We conducted a cross-sectional survey using standard systematic review methodology for study selection and data extraction. We conducted descriptive analyses. We collected data from papers published in 2016 in 'health policy and service journals' category in Web of Science database. We included primary studies (eg, randomised controlled trials, cohort studies, qualitative studies) of HPSR published in English in 2016 peer-reviewed health policy and services journals. Reported COI disclosures including whether authors reported COI or not, form in which COI disclosures were provided, number of authors per paper who report any type of COI, number of authors per paper who report specific types and subtypes of COI. We included 200 eligible primary studies of which 132 (66%) included COI disclosure statements of authors. Of the 132 studies, 19 (14%) had at least one author reporting at least one type of COI and the most frequently reported type was individual financial COI (n=15, 11%). None of the authors reported individual intellectual COIs or personal COIs. Financial and individual COIs were reported more frequently compared with non-financial and institutional COIs. A low percentage of HPSR primary studies included authors reporting COI. Non-financial or institutional COIs were the least reported types of COI.

Identifiants

pubmed: 32690493
pii: bmjopen-2019-032425
doi: 10.1136/bmjopen-2019-032425
pmc: PMC7371338
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e032425

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MBH, GG and EAA have competing interests related to their research in the area of conflicts of interest.

Références

PLoS One. 2016 Sep 08;11(9):e0162198
pubmed: 27606602
Health Res Policy Syst. 2018 Aug 17;16(1):83
pubmed: 30119673
Health Res Policy Syst. 2013 Aug 08;11:30
pubmed: 23924162
Plast Reconstr Surg. 2017 Sep;140(3):635-639
pubmed: 28841626
PLoS Med. 2011 Aug;8(8):e1001079
pubmed: 21886488
Health Res Policy Syst. 2017 Sep 19;15(1):80
pubmed: 28927424
Child Care Health Dev. 2008 Sep;34(5):682-95
pubmed: 18796060
J Agromedicine. 2012;17(2):109-26
pubmed: 22490025
World J Surg. 2018 Sep;42(9):2757-2762
pubmed: 29426969
Am J Sports Med. 2018 Mar;46(4):969-976
pubmed: 29382212
PLoS Med. 2013 Dec;10(12):e1001578; dicsussion e1001578
pubmed: 24391479
BMJ Open. 2016 Mar 02;6(3):e010442
pubmed: 26936908
Lancet. 2004 Oct 30-Nov 5;364(9445):1615-21
pubmed: 15519634
Tob Control. 2003 Mar;12(1):13-20
pubmed: 12612356
PLoS One. 2016 Mar 31;11(3):e0152301
pubmed: 27030966
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Clin Epidemiol. 2017 Jul;87:78-86
pubmed: 28412465
Am J Respir Crit Care Med. 2009 Sep 15;180(6):564-80
pubmed: 19734351
J Urol. 2019 Feb;201(2):393-399
pubmed: 30053509
Int J Health Policy Manag. 2018 Feb 12;7(8):711-717
pubmed: 30078291
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Syst Rev. 2014 Nov 18;3:122
pubmed: 25417178
BMJ Open. 2016 Aug 10;6(8):e011997
pubmed: 27515760
Health Res Policy Syst. 2015 Feb 25;13:10
pubmed: 25971248
Health Res Policy Syst. 2009 Dec 16;7 Suppl 1:S1
pubmed: 20018099
Am J Clin Oncol. 2011 Oct;34(5):524-8
pubmed: 21441858
Ann Surg. 2018 Jul;268(1):86-92
pubmed: 28700443
BMC Health Serv Res. 2012 Jul 16;12:200
pubmed: 22799440

Auteurs

Maram B Hakoum (MB)

Clinical Research Institute, American University of Beirut, Beirut, Lebanon.

Lama Bou-Karroum (L)

Center for Systematic Reviews for Health Policy and Systems Research, American University of Beirut, Beirut, Lebanon.
Department of Health Management and Policy, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.

Mounir Al-Gibbawi (M)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Assem M Khamis (AM)

Clinical Research Institute, American University of Beirut, Beirut, Lebanon.

Abdul Sattar Raslan (AS)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Sanaa Badour (S)

Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Arnav Agarwal (A)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Fadel Alturki (F)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Gordon Guyatt (G)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Fadi El-Jardali (F)

Department of Health Management and Policy, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Knowledge to Policy (K2P) Center, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.

Elie A Akl (EA)

Clinical Research Institute, American University of Beirut, Beirut, Lebanon ea32@aub.edu.lb.
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH